Status:
COMPLETED
Study of Tumor Samples From Patients With Lung Cancer
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE:...
Detailed Description
OBJECTIVES: Primary * To determine the correlation between c-Met expression, mutation and amplification, with stage and overall survival in patients with adenocarcinoma (AC) of the lung. Secondary ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Registration to Cancer and Leukemia Group B (CALGB) 140202
- Institutional Review Board (IRB) review and approval at the institution where the laboratory work will be performed is required
- Informed consent: the CALGB does not require that a separate consent form be signed for this study
- The subject population to be studied in this protocol includes patients selected from CALGB 140202; all such patients have signed a written informed consent document meeting all federal, state, and institutional guidelines as part of entry into that trial
- All samples to be studied were obtained and stored as part of CALGB 140202; the material and data obtained from the patient's protocol record will be used to obtain appropriate clinical information; in no instance will the patient be contacted directly
- There should be no physical, psychological, social, or legal risks associated with this study; no invasive procedures are recommended or requested
- All appropriate and necessary procedures will be utilized to maintain confidentiality; all patients who have had samples submitted for analysis will have their CALGB study number used to identify specimens
- This study does not require direct patient contact and no specific risk or benefits to individuals involved in the trial are anticipated; it is likely, however, that the information gained will substantially help similar patients in the future
Exclusion
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT00900328
Start Date
September 1 2008
End Date
September 1 2012
Last Update
August 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Boston, Massachusetts, United States, 02115